A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose

about

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose

Item

http://www.wikidata.org/entity/Q56901675

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@en

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@nl

type

Item

label

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@en

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@nl

prefLabel

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@en

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@nl

P1476

A Bovine Adenoviral Vector-Bas ...... on at a Significantly Low Dose

@en

P2093

Ahmed O Hassan

http://www.w3.org/2001/XMLSchema#string

Ekramy E Sayedahmed

http://www.w3.org/2001/XMLSchema#string

Ian York

http://www.w3.org/2001/XMLSchema#string

Rashmi Kumari

http://www.w3.org/2001/XMLSchema#string

Shivaprakash Gangappa

http://www.w3.org/2001/XMLSchema#string

Suresh K Mittal

http://www.w3.org/2001/XMLSchema#string

Suryaprakash Sambhara

http://www.w3.org/2001/XMLSchema#string

Weiping Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.

Production of adenovirus vectors and their use as a delivery system for influenza vaccines.

Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Cell-mediated protection in influenza infection.

Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time

P304

210-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTM.2018.07.007

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30101154

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

P932

6082999

http://www.w3.org/2001/XMLSchema#string